Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease (Q32063818)

6 July 2017

1 reference

title

Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease (English)

1 reference

6 July 2017

0 references

1 reference

coronary artery disease

1 reference

Stein BC

1

1 reference

PubMed ID

9588425

6 July 2017

Levin RI

series ordinal

2

1 reference

PubMed ID

9588425

6 July 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

6 July 2017

American Heart Journal

1 reference

6 July 2017

135

1 reference

6 July 2017

5 Pt 1

1 reference

6 July 2017

914-923

1 reference

The possible role of cardiac atrial stretch receptors in the induction of changes in urine flow

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

A new natriuretic peptide in porcine brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Nucleotide sequences of the human and mouse atrial natriuretic factor genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Human and canine gene homologs of porcine brain natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Effect of atrial peptides on aldosterone production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

The protein kinase domain of the ANP receptor is required for signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Endothelin stimulates basal and stretch-induced atrial natriuretic peptide secretion from the perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Angiotensin II directly stimulates release of atrial natriuretic factor in isolated rabbit hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Rapid changes of atrial natriuretic peptide concentration during percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Release of atrial natriuretic peptide in relation to metabolic changes during myocardial ischaemia induced by coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

The Neurohumoral Axis in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Increased plasma levels of B-type natriuretic peptide in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Relationship between plasma level of brain natriuretic peptide and myocardial infarct size.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Cardiovascular effects of intracoronary atrial natriuretic peptide administration in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Effects of atrial natriuretic peptide in the canine coronary circulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Renal, hormonal, and hemodynamic effects of low-dose infusion of atrial natriuretic factor in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Improvement in exercise-induced left ventricular dysfunction by infusion of alpha-human atrial natriuretic peptide in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Suppression of hyperventilation-induced attacks with infusion of B-type (brain) natriuretic peptide in patients with variant angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970054-7

10.1016/S0002-8703(98)70054-7

7 January 2021

Identifiers

DOI

1 reference

6 July 2017

1 reference

PubMed ID

9588425